Results 181 to 190 of about 995,258 (307)

No Evidence for an Association Between DIP2B Repeat Expansion and Neurological Disease

Movement Disorders, EarlyView.
Chia‐Ying Ko, Leon Schütz, Thomas Braun, Elena Buena‐Atienza, Nicolas Casadei, Danique Beijer, Ludger Schöls, Tobias B. Haack, Stephan Ossowski, Holger Hengel   +9 more
wiley   +1 more source

Online Crowdfunding Campaigns for People Living With ALS Demonstrate Financial Burden and Unmet Needs

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims People living with amyotrophic lateral sclerosis (ALS; pALS) have extensive care needs, from wheelchairs to feeding tubes to caregiving support. The financial impact of these needs on pALS and their caregivers (cALS) has not been fully explored.
Astrid Grouls, Peter A. Ubel, Minh Nguyen, Nikhita Pathapati, Steven Doerstling, Caroline E. Sloan   +5 more
wiley   +1 more source

Appendicular Skeletal Muscle Mass and Sarcopenia as Prognostic Markers in Amyotrophic Lateral Sclerosis. [PDF]

J Cachexia Sarcopenia Muscle
Zarco-Martín MT, Andreo-López MC, Yagui-Beltrán MS, Fernández-Soto ML.   +3 more
europepmc   +1 more source

Serum Neurofilament Light Chain and GFAP in Amyotrophic Lateral Sclerosis on a Commercial ECLIA Platform

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims In amyotrophic lateral sclerosis (ALS), SIMOA‐based studies show that baseline serum neurofilament light chain (NfL) predicts the revised ALS Functional Rating Scale (ALSFRS‐R) decline rate and survival. The Roche Elecsys electrochemiluminescence immunoassay (ECLIA) reports values approximately six‐fold lower; cross‐platform ...
Nicholas S. Streicher
wiley   +1 more source

New Hopes and Challenges for Treatment of Neurodegenerative Disorders: Great Opportunities for Young Neuroscientists

Basic and Clinical Neuroscience, 2013
Mahmoud Kiaei
doaj  

Implementation of specialised care improves survival in patients with amyotrophic lateral sclerosis. [PDF]

Neurol Res Pract
Keritam O, Bormann D, Haimberger F, Gharib D, Sener M, Gruber F, Antoniewicz L, Fedak I, Renner A, Fasching B, Ullrich S, Paternostro R, Dolak W, Masel EK, Schuhfried O, Rath J, Zulehner G, Krenn M, Zimprich F, Cetin H.   +19 more
europepmc   +1 more source

Mimickers of Amyotrophic Lateral Sclerosis

Annals of Indian Academy of Neurology, 2019
Ayush Dubey, Shubham Dubey
openaire   +3 more sources

Emergencies in Amyotrophic Lateral Sclerosis

Muscle &Nerve, EarlyView.
ABSTRACT Emergencies are frequent in people living with amyotrophic lateral sclerosis (pALS), especially as the disease progresses, and can necessitate urgent evaluation and intervention. Progressive weakness in ALS inevitably increases fall risk, making discussion of fall prevention strategies integral to caring for pALS.
S. Pinar Uysal, Katherine A. Dudley, Stacey Sullivan, Kate T. Brizzi, Katherine M. Burke, Sydney Hall, Kiersten Pease, Joshua N. Goldstein, James D. Berry, Doreen T. Ho   +9 more
wiley   +1 more source

Disrupted astrocyte-neuron metabolic coupling in amyotrophic lateral sclerosis. [PDF]

Front Cell Dev Biol
Heffernan ÁB, Do F, Carter E, Al-Tameemi F, Selvaraj BT, Stavrou M.   +5 more
europepmc   +1 more source

Prime editing in neuropsychiatric disorders: From mutation‐specific target selection to clinical translation

Neuroprotection, EarlyView.
Abstract Prime editing, a novel clustered regularly interspaced short palindromic repeats (CRISPR)‐based technology, fuses a reverse transcriptase (RT) to an engineered CRISPR‐associated protein 9 (Cas9) and uses a prime editing guide RNA (pegRNA)‐encoded template.
Tianshan Ji, Yuan Zhang, Jinyi Zhao, Yiping Lu, Chengkun Wang   +4 more
wiley   +1 more source